Aspirin
Clinical trials for Aspirin explained in plain language.
Never miss a new study
Get alerted when new Aspirin trials appear
Sign up with your email to follow new studies for Aspirin, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
A 7,000-Person trial asks: is lifelong aspirin necessary for older hearts?
Disease control Not yet recruitingThe RELEASE trial tests whether adults aged 65 and older with stable ischemic heart disease can safely stop their daily low-dose aspirin. Researchers will compare stopping aspirin against continuing it in 7,000 participants who have been free of heart events for at least two year…
Matched conditions: ASPIRIN
Phase 4 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a daily pill and a simple physical therapy delay moyamoya strokes?
Disease control Not yet recruitingThis trial tests whether aspirin and a non-invasive physical therapy called ischemic conditioning can slow the progression of moyamoya disease, a rare brain vessel disorder that can cause strokes and cognitive decline. The study enrolls adults with moyamoya disease or syndrome wh…
Matched conditions: ASPIRIN
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could LVAD patients ditch aspirin? new trial aims to find out
Disease control Not yet recruitingThis study tests whether patients with a heart pump (LVAD) can safely stop taking aspirin while continuing warfarin. The goal is to reduce bleeding problems without increasing dangerous clots. About 370 participants will be randomly assigned to receive either aspirin or a placebo…
Matched conditions: ASPIRIN
Phase 4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC